A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(8 sites)
China
Hechi Yizhou District Center for Disease Control and Prevention, Hechi, Guangxi Hezhou Center for Disease Control and Prevention, Hezhou, Guangxi Lianyuan Center for Disease Control and Prevention, Lianyuan, Hunan Qiyang Center for Disease Control and Prevention, Wuxi, Hunan Yongji Center for Disease Control and Prevention, Yongji, Shanxi Yuanqu Center for Disease Control and Prevention, Yuncheng, Shanxi Mianyang Youxian District Center for Disease Control and Prevention, Mianyang, Sichuan Neijiang Shizhong District Center for Disease Control and Prevention, Neijiang, Sichuan Age range
18 Years – 45 Years
Last updated January 2026